Dr. Bertrand Lebouché is an assistant professor in the Division of Infectious Diseases of the Faculty of Medicine at McGill University as well as a junior scientist at the Research Institute of the McGill University Health Centre.
Dr. Lebouché’s research focuses on three areas, two of which he is pursuing in CTN studies. The first is sexual health and antiretroviral therapy as HIV prevention, which he is pursuing in CTNPT 013. This pilot trial is evaluating how effective sessions with a sexologist are in improving sexual health and reducing HIV transmission risk in couples of men who have sex with men with one HIV-positive partner.
The second is the optimization of antiretroviral therapy, which he is pursuing in CTN 283, a study aiming to develop a measure antiretroviral therapy’s interference with life in order to better understand the impacts of ART on people living with HIV. Finally, CTNPT 006 is a pilot trial aiming to determine the effectiveness of a drug (Niaspan) in reducing immune activation and increase CD4 cell levels in persons with sub-optimal responses to antiretroviral therapy.
